# ERYTHROMYCIN LACTOBIONATE
> **ANDA215290** · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2022-02-14
## Drug
- **FDA Application Number:** ANDA215290
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERYTHROMYCIN LACTOBIONATE
- **Generic name:** Erythromycin Lactobionate
- **Active ingredients:** ERYTHROMYCIN LACTOBIONATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NEXUS
- **First approval:** 2022-02-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215290)
---
*MORVS · CC0 1.0*